<DOC>
	<DOC>NCT00215007</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of levofloxacin to prevent bacterial infections in the postneutropenic period in patients who have undergone allogeneic stem cell transplantation (SCT).</brief_summary>
	<brief_title>Trial of Levofloxacin as Prophylaxis After Allogeneic Stem Cell Transplantation (SCT)</brief_title>
	<detailed_description />
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>Allogeneic SCT Postneutropenic period Written consent Fever Antibiotic therapy Neutropenia Refusal by the patient</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2004</verification_date>
</DOC>